PURPOSE: Zinc levels have been correlated with cancer risk, although the role of zinc and zinc transporters in cancer progression is largely unknown. We recently found that a zinc transporter, ZIP4, is overexpressed in pancreatic cancer. In this study, we further deciphered the role that ZIP4 plays in a pancreatic cancer mouse model by silencing ZIP4. EXPERIMENTAL DESIGN: ZIP4 stable silencing was established in pancreatic cancer cell lines ASPC-1 (ASPC-shZIP4) and BxPC-3 (BxPC-shZIP4) by short hairpin RNA using retrovirus vectors. The stable cells were characterized in vitro and in vivo using a nude mouse xenograft model. RESULTS: Silencing of ZIP4 was associated with decreased cell proliferation, migration, and invasion. Both ASPC-shZIP4 and BxPC-shZIP4 cells showed a significant reduction in tumor volume and weight in the s.c. model, and decreased primary tumor weight in the orthotopic model compared with the vector control cells (ASPC-shV and BxPC-shV). Silencing of ZIP4 also caused reduced incidence of tumor metastasis in the mice and downsized the tumor grade. More importantly, silencing of ZIP4 significantly increased the survival rate of nude mice with orthotopic xenografts (P = 0.005). All ASPC-shZIP4-injected mice (100%) remained alive up to 32 days after tumor implantation, whereas only 30% of the ASPC-shV mice were alive at the same time point. CyclinD1 expression was decreased in the ASPC-shZIP4 xenografts. CONCLUSIONS: These results identify a previously uncharacterized role of ZIP4 in pancreatic cancer progression, and indicate that knocking down ZIP4 by short hairpin RNA might be a novel treatment strategy for pancreatic cancers with ZIP4 overexpression.
PURPOSE: Zinc levels have been correlated with cancer risk, although the role of zinc and zinc transporters in cancer progression is largely unknown. We recently found that a zinc transporter, ZIP4, is overexpressed in pancreatic cancer. In this study, we further deciphered the role that ZIP4 plays in a pancreatic cancermouse model by silencing ZIP4. EXPERIMENTAL DESIGN:ZIP4 stable silencing was established in pancreatic cancer cell lines ASPC-1 (ASPC-shZIP4) and BxPC-3 (BxPC-shZIP4) by short hairpin RNA using retrovirus vectors. The stable cells were characterized in vitro and in vivo using a nude mouse xenograft model. RESULTS: Silencing of ZIP4 was associated with decreased cell proliferation, migration, and invasion. Both ASPC-shZIP4 and BxPC-shZIP4 cells showed a significant reduction in tumor volume and weight in the s.c. model, and decreased primary tumor weight in the orthotopic model compared with the vector control cells (ASPC-shV and BxPC-shV). Silencing of ZIP4 also caused reduced incidence of tumor metastasis in the mice and downsized the tumor grade. More importantly, silencing of ZIP4 significantly increased the survival rate of nude mice with orthotopic xenografts (P = 0.005). All ASPC-shZIP4-injected mice (100%) remained alive up to 32 days after tumor implantation, whereas only 30% of the ASPC-shV mice were alive at the same time point. CyclinD1 expression was decreased in the ASPC-shZIP4 xenografts. CONCLUSIONS: These results identify a previously uncharacterized role of ZIP4 in pancreatic cancer progression, and indicate that knocking down ZIP4 by short hairpin RNA might be a novel treatment strategy for pancreatic cancers with ZIP4 overexpression.
Authors: Li Jiao; Panagiota N Mitrou; Jill Reedy; Barry I Graubard; Albert R Hollenbeck; Arthur Schatzkin; Rachael Stolzenberg-Solomon Journal: Arch Intern Med Date: 2009-04-27
Authors: M Juhász; J Chen; U Lendeckel; U Kellner; H-U Kasper; Z Tulassay; S Pastorekova; P Malfertheiner; M P A Ebert Journal: Aliment Pharmacol Ther Date: 2003-10-15 Impact factor: 8.171
Authors: Leslie C Costello; Bernard A Levy; Mohamed M Desouki; Jing Zou; Omar Bagasra; Leslie A Johnson; Nader Hanna; Renty B Franklin Journal: Cancer Biol Ther Date: 2011-08-15 Impact factor: 4.742
Authors: Benjamin P Weaver; Yuxia Zhang; Stephen Hiscox; Grace L Guo; Udayan Apte; Kathryn M Taylor; Christian T Sheline; Li Wang; Glen K Andrews Journal: PLoS One Date: 2010-10-04 Impact factor: 3.240
Authors: Yi Lin; Yong Chen; Yongzhi Wang; Jingxuan Yang; Vivian F Zhu; Yulun Liu; Xiaobo Cui; Leon Chen; Wei Yan; Tao Jiang; Georgene W Hergenroeder; Stephen A Fletcher; Jonathan M Levine; Dong H Kim; Nitin Tandon; Jay-Jiguang Zhu; Min Li Journal: Neuro Oncol Date: 2013-04-17 Impact factor: 12.300
Authors: J Yang; Y Zhang; X Cui; W Yao; X Yu; P Cen; S E Hodges; W E Fisher; F C Brunicardi; C Chen; Q Yao; M Li Journal: Curr Mol Med Date: 2013-03 Impact factor: 2.222